Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy

Md Selim Ahmed, Se Eun Byeon, Yideul Jeong, Mohammad Alam Miah, Md Salahuddin, Yoon Lee, Sung Soo Park, Yong Soo Bae

    Research output: Contribution to journalArticlepeer-review

    33 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy'. Together they form a unique fingerprint.

    Keyphrases

    Immunology and Microbiology